Larimar Therapeutics (LRMR) Assets (2013 - 2026)
Larimar Therapeutics' Assets was $165.3 million in Q2 2026, up 10.2% from $149.99 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Assets at Larimar Therapeutics came in at $145.84 million, down 27.2% from FY2024.
- Assets shows a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- In earlier years, Assets was $200.23 million in FY2024 (+108.7%), $95.94 million in FY2023 (-24.1%), $126.41 million in FY2022 (+60.7%) and $78.67 million in FY2021 (-24.9%).
- Quarterly Assets has moved between $62.85 million (Q2 2022) and $248.21 million (Q1 2024) over five years.
- Compared with a year earlier, Assets was higher in three of the last seven quarters, with growth averaging 17.1%.
- The best year-over-year quarter for Assets over five years was Q2 2024 (growth of 112.3%); the worst was Q2 2025 (a decline of 36.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Larimar Therapeutics | 329.31 Mn | -277.77 Mn | - | 165.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.30 Mn |
| Dec 31, 2025 | 145.84 Mn |
| Sep 30, 2025 | 187.35 Mn |
| Jun 30, 2025 | 149.99 Mn |
| Mar 31, 2025 | 170.18 Mn |
| Dec 31, 2024 | 200.23 Mn |
| Sep 30, 2024 | 219.02 Mn |
| Jun 30, 2024 | 237.16 Mn |
| Mar 31, 2024 | 248.21 Mn |
| Dec 31, 2023 | 95.94 Mn |
| Sep 30, 2023 | 103.95 Mn |
| Jun 30, 2023 | 111.72 Mn |
| Mar 31, 2023 | 118.91 Mn |
| Dec 31, 2022 | 126.41 Mn |
| Sep 30, 2022 | 133.02 Mn |
| Jun 30, 2022 | 62.85 Mn |
| Mar 31, 2022 | 71.22 Mn |
| Dec 31, 2021 | 78.67 Mn |
| Sep 30, 2021 | 87.94 Mn |
| Jun 30, 2021 | 80.93 Mn |
API Access
Larimar Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();